JSPRW (STOCKS)
Japer Therapeutics, Inc. Warrants
$0.010200
+0.000000 (+0.00%)
Prev close: $0.010200
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Jeet Mahal, MBA
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- —
- Employees
- 64
- P/E (TTM)
- —
- P/B (TTM)
- —
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Cost Of Revenue | $35.50M |
| Nonoperating Income/Loss | $17.30M |
| Operating Expenses | $73.03M |
| Depreciation and Amortization | $798.00K |
| Research and Development | $52.76M |
| Other Operating Expenses | $19.47M |
| Operating Income/Loss | -$73.03M |
| Income/Loss From Continuing Operations After Tax | -$55.73M |
| Income/Loss From Continuing Operations Before Tax | -$55.73M |
| Net Income/Loss | -$55.73M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$55.73M |
| Net Income/Loss Available To Common Stockholders, Basic | -$55.73M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.58 |
| Diluted Earnings Per Share | -$2.58 |
| Basic Average Shares | 32,817,807 |
| Diluted Average Shares | 32,817,807 |
| Assets | $21.18M |
| Current Assets | $20.29M |
| Noncurrent Assets | $892.00K |
| Fixed Assets | $81.00K |
| Other Non-current Assets | $811.00K |
| Liabilities | $17.78M |
| Current Liabilities | $9.00M |
| Accounts Payable | $2.44M |
| Wages | $1.89M |
| Other Current Liabilities | $4.67M |
| Noncurrent Liabilities | $8.79M |
| Equity | $3.40M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $3.40M |
| Liabilities And Equity | $21.18M |
| Net Cash Flow From Operating Activities | -$68.87M |
| Net Cash Flow From Operating Activities, Continuing | -$68.87M |
| Net Cash Flow | -$34.65M |
| Net Cash Flow, Continuing | -$34.65M |
| Comprehensive Income/Loss | -$55.73M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$55.73M |
| Other Comprehensive Income/Loss | $0.00 |